Nanomix

About

Nanomix, established in 2000 in Emeryville, California, is a pioneering company in nanosensor technology, specializing in carbon nanotube-based electronic biosensors for point-of-care medical diagnostics. The company has raised over $75 million in funding to develop its innovative diagnostic platform that leverages the exceptional electronic and chemical properties of carbon nanotubes for rapid, accurate medical testing. Carbon nanotubes, cylindrical nanostructures with diameters of just a few nanometers, exhibit extraordinary sensitivity to surface chemical changes, making them ideal transducers for biosensing applications. Nanomix's proprietary technology functionalizes carbon nanotubes with specific recognition molecules that bind target biomarkers, causing measurable changes in the nanotubes' electrical conductivity. This direct electronic detection mechanism enables rapid, label-free measurement of clinically relevant analytes. The company's flagship eLab diagnostic system brings laboratory-quality testing to the point of care, providing rapid results for critical biomarkers directly at the patient's bedside, in emergency departments, or in physician offices. The system can measure multiple analytes including blood gases, electrolytes, and metabolites from small blood samples, with results available in minutes rather than the hours typically required for central laboratory testing. This speed enables faster clinical decision-making, particularly critical in acute care settings. The nanosensor technology offers significant advantages including small sample volumes, minimal reagent consumption, and the potential for highly multiplexed testing. Nanomix's platform addresses the growing demand for decentralized diagnostic testing, aligning with trends toward personalized medicine and value-based healthcare. The company's work exemplifies how nanotechnology can transform medical diagnostics, bringing sophisticated analytical capabilities out of centralized laboratories and directly to patients. As point-of-care testing continues to expand globally, Nanomix's carbon nanotube-based sensors represent a significant technological advancement in making rapid, accurate diagnostic information immediately available to healthcare providers.